obesity drug news today glp-1 october 2025 therapies are changing care. What does WHO recommend? Here's what you need to know Obesity GLP-1 Market Size to
Description
Analysis of Obesity GLP-1 Market by Key Country The obesity GLP-1 market is growing rapidly across major economies, with China and the United States both recording 25.4% CAGR through 2035, driven by large treatment-eligible populations and expanding access frameworks
Robert Kushner: I worry about it mostly in an elderly individual, 65 years or older, because starting at about age 30 or so we start losing muscle mass
Heart rate as a risk factor for cardiovascular disease
Hayes MR, Borner T, De Jonghe BC
